Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-27

FDA Approved: TADALAFIL — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved a supplemental application for tadalafil filed by Solco Healthcare US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)